|
DE2163899A1
|
|
Defibrinating enzyme - from snake venom purified by fractionation on cation exchange material
|
|
GB1279859A
|
|
Process for the production of enhanced levels of viral yield
|
|
GB1293795A
|
|
Improvements relating to anticoagulants
|
|
GB1211876A
|
|
Improvements in and relating to prophylactic and therapeutic preparations
|
|
GB1153648A
|
|
Substituted 2-Anilino Benzothiazole Basic Ethers
|
|
GB1153647A
|
|
2-Anilino Benzoxazole Basic Ethers
|
|
GB1063148A
|
|
Improvements in or relating to live cell diluent
|
|
GB1123214A
|
|
Preparation of phosphatidylethanolamine
|
|
GB1091218A
|
|
Preparation of bacterial lipopolysaccharides
|
|
GB1093355A
|
|
2-carbamoylphenylbenzothiazoles
|
|
GB1080246A
|
|
2-aryl-benzothiazole derivatives
|
|
GB1073694A
|
|
Preparation of bacterial lipopolysaccharides
|
|
GB1061336A
|
|
Improvements in or relating to the preservation of viable animal tissues and cells
|
|
CA827641A
|
|
Preparation of bacterial lipopolysaccharides
|
|
CA842248A
|
|
Process for the preparation of basic ethers of anilinobenzoxazoles
|
|
CA827642A
|
|
Phosphatidylethanolamine
|
|
CA820865A
|
|
Preparation of bacterial lipopolysaccharides
|
